Sarah Pearson

Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial

Susan Dutton, David Ferry, Jane Blazeby et al. · The Lancet Oncology · 2014 · 329 citations · Full text

Esophageal Cancer, Gastrointestinal Oncology, Medicine +6

Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study

Brian D Nicholson, Jason Oke, Pradeep S. Virdee et al. · The Lancet Oncology · 2023 · 167 citations · Full text

Application of mobile phone technology for managing chemotherapy-associated side-effects

Andrew Weaver, Annie Young, Joanna Rowntree et al. · Annals of Oncology · 2007 · 158 citations

Oncology, Telehealth, Metronomic Therapy +7

Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial

Rachel Kerr, Sharon Love, Eva Segelov et al. · The Lancet Oncology · 2016 · 147 citations

Gastrointestinal Oncology, Medicine, Adjuvant Capecitabine +9

Randomized controlled trial of primary prevention of atopy using house dust mite allergen oral immunotherapy in early childhood

Zaraquiza Zolkipli, Graham Roberts, Victoria Cornelius et al. · Journal of Allergy and Clinical Immunology · 2015 · 118 citations · Full text

Environmental Allergy, Primary Prevention, Allergy +9